Lung cancer

03 September 2018

Doctors often don't tell patients about risks of lung cancer screening

Lung cancer screenings help patients detect any abnormalities in their lungs. But these screenings may pose risks to your health.

The potential risks of lung cancer screening are often left out when doctors and patients discuss the issue, a new report suggests. In South Africa, lung cancer accounts for 17% of cancer-related deaths. 

Early detection of lung cancer can save lives, and lung cancer screening is recommended for high-risk current and former smokers. But the US Preventive Services Task Force and other organisations say that doctors need to explain the risks as well as the benefits to patients.

Those risks include a high rate of false positives, which can lead to unnecessary follow-up procedures. And in some cases, screening can reveal lung cancer that, left untreated, would not have affected patients in their lifetime, the study authors said.

In this study, researchers analysed 14 recordings of doctors and patients discussing lung cancer screening. On average, the talks lasted less than a minute, the quality of the conversations was poor, and discussion about the potential harms of screening was "virtually non-existent", the investigators found.

The findings were published in the journal JAMA Internal Medicine.

Complex screenings

"We're not taking a side as to whether lung cancer screening is good or bad, but there seems to be a consensus that we should be sharing these complex decisions with patients," said study senior author Dr Daniel Reuland.

"Our fly-on-the-wall sample from real-world practice shows us that's not happening," he added. Reuland is director of the Carolina Cancer Screening Initiative at the UNC Lineberger Comprehensive Cancer Center in Chapel Hill.

"A lot of people [with positive screening results] undergo surveillance, additional scanning, and some people undergo invasive procedures who don't have lung cancer," Reuland said in a University of North Carolina news release.

Potential harms and benefits

"The problem is weighing a small chance of benefit in the form of prolonged life versus a larger chance that a given patient will incur some kind of physical or psychological harm, plus out-of-pocket costs. It's important to talk about those potential harms and benefits with patients when deciding about screening," he suggested.

The US Preventative Services Task Force recommends annual lung cancer screening using low-dose computed tomography (CT) for adults 55 to 80 years old who have been heavy smokers.

Image credit: iStock


Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules